Through multi-center randomized controlled trial studies on preemptive surgical intervention in patients with chronic kidney disease (CKD) - secondary hyperparathyroidism (SHPT), to precisely evaluate the safety and effectiveness during perioperative period, and the long-term outcomes by 1-year follow-up. The follow-ups include the evaluation of the overall quality of life, calcium and phosphorus metabolism, hyperparathyroidism level, vitamin D metabolism, bone mineral density, soft tissue and vascular calcification.
Study Type
OBSERVATIONAL
Enrollment
50
1. Preemptive surgical intervention for CKD-SHPT patients with poor calcium and phosphorus metabolism controlled by drugs; 2. Rapid immunoreactive parathyroid hormone detection technology during peri-operative period.
Safety of preemptive surgical intervention
The rate of post operative complications(including bleeding, infection, adjacent tissue injury) of early precise parathyroidectomy surgery in patients with CKD-SHPT, according to the electronic medical records of the hospital.
Time frame: October 2020 to September 2022
Efficacy of preemptive surgical intervention
The rate of relapse of hyperparathyroidism after parathyroidectomy, according to the immunoreactive parathyroid hormone concentration.
Time frame: October 2020 to September 2022
short-term and long-term mortality
The all-cause mortality rate and cardiovascular and cerebrovascular mortality rate during hospitalization, by Day 60, Day 180 and 1 year during follow-up.
Time frame: October 2020 to September 2022
short-term and long-term bone metabolism
The level of immunoreactive parathyroid hormone, 25(OH)-vitamin D, calcium, phosphate, alkaline phosphatase and biomarker series of bone metabolism during hospitalization, by Day 60, Day 180 and 1 year.
Time frame: October 2020 to September 2022
Medical Outcomes Short-Form Health Survey (SF36) Scale
Medical Outcomes Short-Form Health Survey (SF36) scale on quality of life during hospitalization, by Day 60, Day 180 and 1 year during follow-ups. The minimum value is 0, and the maximum value is 100, and higher scores mean a better outcome.
Time frame: October 2020 to September 2022
cardiovascular function
The left ventricular ejection fraction (%, obtained by echocardiography) during hospitalization, by Day 180 and 1 year during medical visits.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: October 2020 to September 2022
inpatient days
Length of hospitalization, according the electronic medical records.
Time frame: October 2020 to September 2022
hospitalization costs
Cost of hospitalization, according the electronic medical records.
Time frame: October 2020 to September 2022
adverse events associated with metabolic bone disease
e.g. fall down, bone fracture during follow-ups, through medical visits and telephone follow-ups.
Time frame: October 2020 to September 2022